FDA Inspection 661446 — Baxalta US Inc.
The FDA completed an inspection of Baxalta US Inc. on May 13, 2010 in Westlake Village, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 13, 2010
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Westlake Village, CA (United States)